Latest news
What Does Merck’s (NYSE:MRK) Latest Trial Setback Mean? - Kalkine MediaKalkine Media · Sun, 09 Aug 2026 15:11:00 GMTWhat Does Merck (MRK) Lose From Ending Its Late Stage Lung Cancer Trial? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 11:37:53 GMTMerck KGaA (XTRA:MRK) Stock Run Meets Profit Margin Drift - simplywall.stsimplywall.st · Sat, 08 Aug 2026 00:42:34 GMTMerck (MRK) reports $526M in Form 13F equity holdings across 13 positions - Stock TitanStock Titan · Fri, 07 Aug 2026 20:04:13 GMTMerck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug Approvals - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 11:14:16 GMTFDA Accepts Merck's Application to Expand Enflonsia into Second RSV Season - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 16:59:38 GMTHow Stronger 2026 Guidance And New Drug Indications At Merck (MRK) Has Changed Its Investment Story - simplywall.stsimplywall.st · Thu, 06 Aug 2026 13:35:36 GMTMerck is pharma’s most patent-exposed company. Now it’s reinventing itself. - Pharma VoicePharma Voice · Wed, 05 Aug 2026 13:30:22 GMT